Cargando…
Lipid-DNA Nanoparticles as Drug-Delivery Vehicles for the Treatment of Retinal Diseases
Retinal eye diseases are the leading cause of blindness in the Western world. Up to date, the only efficient treatment for many retinal diseases consists of invasive intravitreal injections of highly concentrated drugs. Despite the fact that these injections are unpleasant for the patients, they pot...
Autores principales: | Schnichels, Sven, Simmang, David, Löscher, Marina, Herrmann, Andreas, de Vries, Jan Willem, Spitzer, Martin S., Hurst, José |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961589/ https://www.ncbi.nlm.nih.gov/pubmed/36839853 http://dx.doi.org/10.3390/pharmaceutics15020532 |
Ejemplares similares
-
Topical Drug Delivery to the Posterior Segment of the Eye
por: Löscher, Marina, et al.
Publicado: (2022) -
Cyclosporine A Protects Retinal Explants against Hypoxia
por: Schnichels, Sven, et al.
Publicado: (2021) -
Efficacy of two different thiol-modified crosslinked hyaluronate formulations as vitreous replacement compared to silicone oil in a model of retinal detachment
por: Schnichels, Sven, et al.
Publicado: (2017) -
Establishment of a primary porcine retinal pigment epithelium monolayer to complement retinal ex vivo cultures
por: Fietz, Agnes, et al.
Publicado: (2023) -
Lipid Nanoparticles as Delivery Vehicles for Inhaled Therapeutics
por: Leong, Ellenmae W. X., et al.
Publicado: (2022)